Kemin Industries acquires CJ Bio subsidiary CJ Youtell Biotech 

Kemin Industries has announced the acquisition of CJ Youtell Biotech, the enzymes and fermentation subsidiary of CJ Bio. The acquisition strengthens Kemin’s ability to serve markets such as animal feed, food, aquaculture, textiles, paper and pulp, and biofuel industries.

With this acquisition, Kemin has full ownership of CJ Youtell’s fermentation plants and its enzyme product portfolio, including plants in Shandong and Hunan, China.

“We are pleased to welcome CJ Youtell into the Kemin family,” says Chris Nelson, president and CEO of Kemin Industries. “This acquisition is a bold step forward in our ongoing strategy to provide cutting-edge fermentation solutions directly to our customers. Adding CJ Youtell to our portfolio further enhances Kemin’s expertise and dedication to supply high-quality and innovative enzyme ingredients and solutions across industries and around the world.”

“The acquisition of CJ Youtell marks a powerful expansion of Kemin’s enzyme capabilities,” says Michelle Lim, president of Kemin Enzymes. “For over 40 years, Kemin has been formulating and delivering enzyme solutions across multiple markets and industries. With CJ Youtell’s fermentation expertise now part of our portfolio, we offer customers a fully integrated solution—from proprietary strain development and manufacturing to final formulation and application support.”